Effects of Probiotic Use on Quality of Life and Physical Activity in Constipated Female University Students: A Randomized, Double-Blind Placebo-Controlled Study

被引:12
|
作者
Kommers, Michelle Jalousie [1 ]
Silva Rodrigues, Rosilene Andrade [1 ]
Miyajima, Fabio [2 ]
Zavala Zavala, Arturo Alejandro [1 ]
Leite Moreno Ultramari, Viviane Regina [1 ]
Rezende Fett, Waleria Christiane [1 ]
Balogun, Sikiru Olaitan [3 ]
de Oliveira, Ruberlei Godinho [1 ]
Fett, Carlos Alexandre [1 ]
机构
[1] Univ Fed Mato Grosso, Postgrad Program, Sch Phys Educ, Cuiaba, Brazil
[2] Fundacao Oswaldo Cruz Fiocruz, Dept Sci Technol Prod & Innovat Publ Hlth, Fortaleza, Ceara, Brazil
[3] Fac Noroeste Mato Grosso AJES, Juina, Brazil
关键词
intestinal constipation; probiotics; quality of life; exercise; RESISTANT MALTODEXTRIN; COLONIC TRANSIT; FERMENTED MILK; RISK-FACTORS; METAANALYSIS; SYMPTOMS; WOMEN; PREVALENCE; DISCOMFORT; MICROBIOTA;
D O I
10.1089/acm.2019.0134
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objectives: To evaluate the effect of a probiotic supplement containing two genera and five species of bacteria versus placebo on the quality of life (QoL) in female university students with intestinal constipation (IC). Design: A randomized, double-blind placebo-controlled study was conducted on female university students in a single study center. Settings/Location: Two phases of interventions were carried out, the pilot and main study. All participants were female students of Federal University of Mato Grosso, Brazil. Subjects: Female students whose ages ranged from 20 to 40 years and self-reported to be suffering from IC based on a questionnaire containing Rome III criteria were included. Interventions: Interventions occurred during a period of 30 days in the pilot phase (n = 32) and 15 days in the main study phase (n = 63). The subjects were numbered and randomly divided into experimental probiotic and placebo control groups. Therefore, neither the participants nor the researchers were aware of the allocations of the treatment groups. Outcome measures: The sociodemographic, Rome III, Patient Assessment of Constipation Quality of Life (PAC-QoL) and International Physical Activity questionnaires, and anthropometric measures were utilized. The relative risk (RR) treatment effect, absolute risk reduction (ARR), RR reduction, number needed to treat (NNT), and odds ratio were calculated. Results: Improvement in the QoL (ARR = 14% and p < 0.01) and satisfaction (ARR = 44% and p < 0.01) according to the PAC-QoL questionnaire was observed in the experimental group compared with the control group. For probiotic supplementation, an NNT = 7 was obtained. This implies that for every seven constipated women treated, a worsening in the QoL is prevented in one. An NNT = 1 was obtained concerning satisfaction in the same group of women with respect to the treatment. No clinically significant observations related to the safety of the product were reported. The authors did not detect the effect of exercise intensity on the QoL of participants. Conclusion: The probiotic supplementation had a positive impact on the QoL of constipated female university students.
引用
收藏
页码:1163 / 1171
页数:9
相关论文
共 50 条
  • [31] Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study
    Navarro-Rodriguez, Tomas
    Silva, Fernando Marcuz
    Barbuti, Ricardo Correa
    Mattar, Rejane
    Moraes-Filho, Joaquim Prado
    de Oliveira, Marice Nogueira
    Bogsan, Cristina S.
    Chinzon, Decio
    Eisig, Jaime Natan
    BMC GASTROENTEROLOGY, 2013, 13
  • [32] Treatment of functional dyspepsia with sertraline: A double-blind randomized placebo-controlled pilot study
    Tan, Victoria P. Y.
    Cheung, Tin K.
    Wong, Wai M.
    Pang, Roberta
    Wong, Benjamin C. Y.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (42) : 6127 - 6133
  • [33] The effect of probiotics on functional constipation in adults Double-blind, randomized, placebo-controlled study
    Rosa Mitelmao, Fabiana Cristina
    Bergamaschi, Cristiane de Cassia
    Gerenutti, Marli
    Hachel, Karin
    Silva, Marcus Tolentino
    Balcao, Victor M.
    Duarte Carvalho Vila, Marta Maria
    MEDICINE, 2021, 100 (10) : E24938
  • [34] The Effect of Synbiotic and Probiotic Supplementation on Mental Health Parameters in Patients Undergoing Hemodialysis: A Double-blind, Randomized, Placebo-controlled Trial
    Haghighat, Neda
    Mohammadshahi, Majid
    Shayanpour, Shokouh
    Haghighizadeh, Mohammad Hossein
    Rahmdel, Samaneh
    Rajaei, Majdadin
    INDIAN JOURNAL OF NEPHROLOGY, 2021, 31 (02) : 149 - 156
  • [35] A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression
    Hantsoo, Liisa
    Ward-O'Brien, Deborah
    Czarkowski, Kathryn A.
    Gueorguieva, Ralitza
    Price, Lawrence H.
    Epperson, C. Neill
    PSYCHOPHARMACOLOGY, 2014, 231 (05) : 939 - 948
  • [36] Investigating the impact of probiotic on neurological outcomes in Rett syndrome: A randomized, double-blind, and placebo-controlled pilot study
    Wong, Lee Chin
    Hsu, Chia-Jui
    Wu, Yen-Tzu
    Chu, Hsu-Feng
    Lin, Jui-Hsiang
    Wang, Hsin-Pei
    Hu, Su-Ching
    Tsai, Ying-Chieh
    Tsai, Wen-Che
    Lee, Wang-Tso
    AUTISM, 2024, 28 (09) : 2267 - 2281
  • [37] A randomised, double-blind, placebo-controlled clinical study: the effects of a synbiotic, Lepicol, in adults with chronic, functional constipation
    Cudmore, Sally
    Doolan, Andrea
    Lacey, Sean
    Shanahan, Fergus
    INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2017, 68 (03) : 366 - 377
  • [38] Assessment of a Multispecies Probiotic Supplement for Relief of Seasonal Allergic Rhinitis: A Randomized Double-Blind Placebo-Controlled Trial
    Cox, Amanda J.
    Ramsey, Rebecca
    Ware, Robert S.
    van der Vaart, Isolde
    Cripps, Allan W.
    West, Nicholas P.
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2023, 29 (05): : 313 - 320
  • [39] A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life
    Endicott, Jean
    Rajagopalan, Krithika
    Minkwitz, Margaret
    Macfadden, Wayne
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (01) : 29 - 37
  • [40] Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study
    Grob, J. J.
    Auquier, P.
    Dreyfus, I.
    Ortonne, J. P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (01) : 87 - 93